Bottom line
What is JSMCX's expense ratio?
JSMCX's expense ratio is 1.35%, or about $135 a year on every $10,000 invested. That is more expensive than 92% of target-date funds we track (median 0.59%). It has no front-end sales load. Its expense ratio includes a 0.75% 12b-1 marketing fee.
Updated Oct 27, 2026
JSMCX fee table
| Net expense ratio | 1.35% |
|---|---|
| Gross expense ratio | 1.4% |
| Management fee | 0% |
| 12b-1 (distribution) fee | 0.75% |
| Other expenses | 0.3% |
| Acquired fund fees | 0.35% |
| Fee waiver / reimbursement | -0.05% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Oct 27, 2026
What JSMCX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| JSMCX | $237 | $438 | $761 | $1,534 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.35% expense ratio costs roughly $72,500 in lost growth, versus about $33,900 for the median target-date fund (0.59%).